Efficacy and Safety of Endoxifen in Bipolar I Disorder Patients
NCT06608641
·
clinicaltrials.gov ↗
PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
490
Enrollment
INDUSTRY
Sponsor class
Conditions
Bipolar 1 Disorder
Interventions
DRUG:
Endoxifen enteric-coated tablet (8 mg)
DRUG:
Placebo Tablets
Sponsor
Jina Pharmaceuticals Inc.
Collaborators
[object Object]